SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
76 hedge funds and large institutions have $209M invested in Syros Pharmaceuticals, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
13% less capital invested
Capital invested by funds: $240M → $209M (-$31.6M)
46% less call options, than puts
Call options by funds: $147K | Put options by funds: $270K
Holders
76
Holding in Top 10
1
Calls
$147K
Puts
$270K
Top Buyers
| 1 | +$6.68M | |
| 2 | +$3.01M | |
| 3 | +$2.16M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.93M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.7M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$961K | |
| 3 | -$712K | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$214K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$170K |